SH3TC2 and cancer: In order to fully investigate the expression status and clinical prognostic value of SH3TC2 in human cancers, we employed the integrated database GEPIA to analyze the expression profile of SH3TC2 in more than 30 types of cancer and its relationship with patient survival.